Omnicell Inc header image

Omnicell Inc

OMCL

Equity

ISIN null / Valor 1275961

NASDAQ (2026-03-27)
USD 32.75-6.96%

Omnicell Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Omnicell, Inc. is a publicly traded healthcare technology company that develops and sells medication management solutions for hospitals, health systems, long‑term care facilities and retail pharmacies. Its portfolio combines automated dispensing cabinets and central pharmacy robotics with software for pharmacy management, inventory control, analytics and medication adherence programs, together with implementation, support and consulting services. Customers use Omnicell’s products to automate drug distribution, track and reconcile inventory, standardize workflows and support outpatient adherence and home delivery programs, generating revenue from equipment sales, software licenses and recurring service contracts. The company is headquartered in Mountain View, California, and positions itself at the intersection of clinical workflow automation and supply‑chain management within healthcare.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-7.36%1Y
-41.8%3Y
-76.6%5Y

Performance

47.3%1Y
51.1%3Y
49.6%5Y

Volatility

Market cap

1488 M

Market cap (USD)

Daily traded volume (Shares)

443,345

Daily traded volume (Shares)

1 day high/low

43.68 / 42.81

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.74%CHF 80.20
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.80%CHF 14.82
Sanofi SA
Sanofi SA Sanofi SA Valor: 699381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.04%EUR 81.99
Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.90%USD 23.49
Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%EUR 62.08
Outset Medical Inc
Outset Medical Inc Outset Medical Inc Valor: 56717137
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%USD 3.56
Bausch Health Companies Inc
Bausch Health Companies Inc Bausch Health Companies Inc Valor: 42260834
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.49%USD 5.04
SOLVENTUM CORP
SOLVENTUM CORP SOLVENTUM CORP Valor: 133635906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.01%USD 62.76
BeiGene Ltd
BeiGene Ltd BeiGene Ltd Valor: 30165310
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.20%USD 283.03
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.45%USD 3.39